Perceptive Advisors as of June 30, 2019
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 103 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Solid Biosciences | 9.4 | $452M | 3.9M | 115.00 | |
Neurocrine Biosciences (NBIX) | 7.1 | $340M | 4.0M | 84.43 | |
Global Blood Therapeutics In | 6.3 | $304M | 5.8M | 52.60 | |
Mirati Therapeutics | 6.2 | $299M | 2.9M | 103.00 | |
Iovance Biotherapeutics (IOVA) | 6.1 | $292M | 12M | 24.52 | |
Amicus Therapeutics (FOLD) | 5.6 | $268M | 22M | 12.48 | |
Athenex | 3.9 | $188M | 9.8M | 19.10 | |
Bridgebio Pharma (BBIO) | 3.8 | $181M | 6.7M | 26.97 | |
Zogenix | 3.5 | $168M | 3.5M | 47.78 | |
Meiragtx Holdings (MGTX) | 3.2 | $156M | 6.0M | 25.93 | |
Amarin Corporation (AMRN) | 2.5 | $120M | 6.2M | 19.39 | |
Blueprint Medicines (BPMC) | 2.4 | $114M | 1.2M | 94.33 | |
Quotient | 2.1 | $101M | 11M | 9.35 | |
Arena Pharmaceuticals | 1.7 | $81M | 1.4M | 58.63 | |
Retrophin | 1.6 | $76M | 3.8M | 20.09 | |
Nevro (NVRO) | 1.5 | $74M | 1.1M | 64.83 | |
Crinetics Pharmaceuticals In (CRNX) | 1.4 | $65M | 2.6M | 25.00 | |
Myokardia | 1.1 | $55M | 1.1M | 50.14 | |
Albireo Pharma | 1.1 | $55M | 1.7M | 32.24 | |
Ascendis Pharma A S (ASND) | 1.1 | $55M | 474k | 115.15 | |
Zymeworks | 1.1 | $52M | 2.4M | 22.00 | |
Dova Pharmaceuticals | 1.1 | $50M | 3.6M | 14.10 | |
Regenxbio Inc equity us cm (RGNX) | 1.0 | $50M | 971k | 51.37 | |
Merit Medical Systems (MMSI) | 1.0 | $49M | 817k | 59.56 | |
Array BioPharma | 1.0 | $48M | 1.0M | 46.33 | |
Viewray (VRAYQ) | 1.0 | $48M | 5.5M | 8.81 | |
Adma Biologics (ADMA) | 0.9 | $45M | 12M | 3.87 | |
Allogene Therapeutics (ALLO) | 0.9 | $42M | 1.5M | 26.85 | |
Verrica Pharmaceuticals (VRCA) | 0.8 | $40M | 3.4M | 11.62 | |
Kodiak Sciences (KOD) | 0.8 | $37M | 3.1M | 11.70 | |
Momenta Pharmaceuticals | 0.8 | $36M | 2.9M | 12.45 | |
Spark Therapeutics | 0.8 | $36M | 350k | 102.38 | |
Cytomx Therapeutics (CTMX) | 0.7 | $35M | 3.2M | 11.22 | |
eHealth (EHTH) | 0.7 | $33M | 386k | 86.10 | |
Vapotherm | 0.7 | $32M | 1.4M | 23.00 | |
Invitae (NVTAQ) | 0.7 | $32M | 1.3M | 23.50 | |
Neptune Wellness Solutions I | 0.6 | $30M | 8.9M | 3.37 | |
Dbv Technologies S A (DBVT) | 0.6 | $30M | 3.6M | 8.22 | |
Rocket Pharmaceuticals (RCKT) | 0.6 | $30M | 2.0M | 15.00 | |
Cymabay Therapeutics | 0.6 | $28M | 3.9M | 7.16 | |
Establishment Labs Holdings Ord (ESTA) | 0.6 | $28M | 1.3M | 21.99 | |
Kadmon Hldgs | 0.6 | $27M | 13M | 2.06 | |
Concert Pharmaceuticals I equity | 0.6 | $27M | 2.2M | 12.00 | |
Vbi Vaccines | 0.5 | $25M | 26M | 0.95 | |
Protagonist Therapeutics | 0.5 | $25M | 2.1M | 12.11 | |
Uniqure Nv (QURE) | 0.5 | $22M | 282k | 78.15 | |
Eidos Therapeutics | 0.5 | $21M | 687k | 31.08 | |
Teladoc (TDOC) | 0.4 | $20M | 307k | 66.41 | |
Stoke Therapeutics (STOK) | 0.4 | $20M | 672k | 29.17 | |
Aldeyra Therapeutics (ALDX) | 0.4 | $19M | 3.1M | 6.00 | |
Turning Point Therapeutics I | 0.4 | $17M | 425k | 40.70 | |
Molecular Templates | 0.3 | $17M | 2.0M | 8.35 | |
Marker Therapeutics Ord | 0.3 | $16M | 2.0M | 7.92 | |
Bausch Health Companies (BHC) | 0.3 | $15M | 600k | 25.22 | |
Urovant Sciences | 0.3 | $15M | 1.9M | 7.91 | |
Adaptive Biotechnologies Cor (ADPT) | 0.3 | $14M | 285k | 48.30 | |
Motus Gi Hldgs Incorporated | 0.3 | $13M | 4.2M | 3.03 | |
Morphic Hldg (MORF) | 0.3 | $13M | 650k | 19.82 | |
Axonics Modulation Technolog (AXNX) | 0.2 | $12M | 286k | 40.97 | |
Ideaya Biosciences (IDYA) | 0.2 | $11M | 1.1M | 9.96 | |
Mei Pharma | 0.2 | $11M | 4.4M | 2.50 | |
Foamix Pharmaceuticals | 0.2 | $11M | 4.7M | 2.38 | |
Agile Therapeutics | 0.2 | $10M | 8.4M | 1.24 | |
Fiat Chrysler Automobiles N | 0.2 | $10M | 62k | 161.42 | |
Dex (DXCM) | 0.2 | $9.0M | 60k | 149.83 | |
Ani Pharmaceuticals Inc. note 3.000 12/0 | 0.2 | $9.0M | 7.5M | 1.20 | |
Aquestive Therapeutics | 0.2 | $8.9M | 2.1M | 4.20 | |
Alector (ALEC) | 0.2 | $9.3M | 512k | 18.22 | |
Acorda Therapeutics | 0.2 | $8.6M | 1.1M | 7.67 | |
Arrowhead Pharmaceuticals (ARWR) | 0.2 | $8.8M | 331k | 26.50 | |
Shockwave Med (SWAV) | 0.2 | $8.6M | 150k | 57.09 | |
Seres Therapeutics (MCRB) | 0.2 | $8.1M | 2.5M | 3.22 | |
Intercept Pharmaceuticals In | 0.2 | $7.8M | 98k | 79.57 | |
Synlogic | 0.2 | $7.9M | 868k | 9.10 | |
Orchard Therapeutics Plc ads | 0.1 | $7.3M | 522k | 13.99 | |
Vocera Communications | 0.1 | $6.2M | 194k | 31.92 | |
Tenet Healthcare Corporation (THC) | 0.1 | $6.2M | 301k | 20.66 | |
Rhythm Pharmaceuticals (RYTM) | 0.1 | $5.8M | 263k | 22.00 | |
Translate Bio | 0.1 | $5.5M | 435k | 12.63 | |
Rockwell Medical Technologies | 0.1 | $4.5M | 1.5M | 3.01 | |
Health Sciences Acqustn Corp unit 04/01/2024 | 0.1 | $4.2M | 400k | 10.60 | |
Twist Bioscience Corp (TWST) | 0.1 | $3.2M | 111k | 29.01 | |
Female Health (VERU) | 0.1 | $3.1M | 1.4M | 2.13 | |
Acasti Pharma | 0.0 | $2.0M | 1.8M | 1.14 | |
CryoLife (AORT) | 0.0 | $1.5M | 50k | 29.94 | |
Axsome Therapeutics (AXSM) | 0.0 | $1.4M | 54k | 25.74 | |
Eiger Biopharmaceuticals | 0.0 | $1.5M | 140k | 10.59 | |
Sierra Oncology | 0.0 | $1.5M | 2.7M | 0.56 | |
Ferrari Nv Ord (RACE) | 0.0 | $1.0M | 6.2k | 161.45 | |
Voyager Therapeutics (VYGR) | 0.0 | $996k | 37k | 27.23 | |
Medicines Company | 0.0 | $712k | 20k | 36.45 | |
ZIOPHARM Oncology | 0.0 | $528k | 91k | 5.83 | |
D Fluidigm Corp Del (LAB) | 0.0 | $567k | 46k | 12.32 | |
Abeona Therapeutics Inc *w exp 12/19/201 | 0.0 | $620k | 660k | 0.94 | |
Natera (NTRA) | 0.0 | $401k | 15k | 27.56 | |
Tandem Diabetes Care (TNDM) | 0.0 | $414k | 6.4k | 64.47 | |
Allena Pharmaceuticals | 0.0 | $539k | 132k | 4.07 | |
Guardant Health (GH) | 0.0 | $571k | 6.6k | 86.29 | |
Mereo Biopharma Group Plc ads (MREO) | 0.0 | $452k | 179k | 2.52 | |
Conformis | 0.0 | $436k | 100k | 4.36 | |
Biogen Idec (BIIB) | 0.0 | $64k | 200k | 0.32 | |
SPDR S&P Biotech (XBI) | 0.0 | $70k | 200k | 0.35 | |
Outlook Therapeutics Inc *w exp 02/18/201 | 0.0 | $46k | 421k | 0.11 |